Have you looked? This was just in 15 minutes over my morning coffee. I think there might be a reason for Bisantrene being a 'forgotten' drug.
Sorry about the formatting.Moderate to Life threatening leukopenia as dose limiting toxicity at 220 mg/sqm/week after two weeks in 4 out of 5 patients. Severe swelling for 6 months.
Alberts, D. S., Mackel, C., Pocelinko, R., & Salmon, S. E. (1982). Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay. Cancer research, 42(3), 1170–1175.
Anaphylactoid Reaction
300 mg/sqm (40 pts 9 PR, 18 SD)
Yap, H.-Y., Yap, B.-S.,Blumenschein, G. R., Barnes, B. C., Schell, F. C., & Bodey, G. P. (1983).Bisantrene, an Active New Drug in the Treatment of Metastatic Breast Cancer. Cancer Research, 43(3), 1402.
Anaphylactoid Reactions in 9 out of 93 patients, lifethreatening toxicity.
Myers, J. W., Von Hoff, D. D., Kuhn, J. G., Osborne, C. K.,Sandbach, J. F., & Pocelinko, R. (1983). Anaphylactoid reactions associatedwith bisantrene infusions. Investigational new drugs, 1(1),85–88.
Myelosupression.
Osborne, C. K., Von Hoff, D. D., Cowan, J. D., &Sandbach, J. (1984). Bisantrene, an active drug in patients with advancedbreast cancer. Cancer treatment reports, 68(2), 357–360.
43 adverse effects recorded amongst 10 patients. Numerousgrade 3 & 4 SAEs and one 5, including leukopenia, thrombocytopenia, cardiacinfarct and mucositis.
Canaani, J., Danylesko, I., Shemtov, N., Zlotnick, M., Lozinsky,K., Benjamini, O., Yerushalmi, R., Nagar, M., Dor, C., Shimoni, A., Avigdor,A., & Nagler, A. (2021). A phase II study of bisantrene in patients withrelapsed/refractory acute myeloid leukemia. European journal of haematology,106(2), 260–266.
- Forums
- ASX - By Stock
- PD1-vaxx and B-vaxx: Kaumaya article in Brit ash Journal of Cancer
Have you looked? This was just in 15 minutes over my morning...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1921794 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 1368288 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 286362 | 0.055 |
9 | 2036888 | 0.054 |
16 | 2736044 | 0.053 |
20 | 1943436 | 0.052 |
23 | 3206056 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 378902 | 2 |
0.058 | 1552127 | 7 |
0.059 | 837099 | 8 |
0.060 | 2176188 | 16 |
0.061 | 1163926 | 6 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online